Mirati Therapeutics (MRTX)
$42.47
0.48 (1.14%)
Why Is Mirati Therapeutics (MRTX) Stock Up Today?
Mirati Therapeutics (MRTX) stock is rising on Thursday as investors react to a special designation from the FDA for adagrasib.
11 Best Stocks to Buy for 2023

INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.19B
PE Ratio
-3.31
EPS
-12.83
Volume (Avg. Vol.)
545,668
Day's Range
$41.96 - $43.74
52-Week Range
$27.30 - $101.30
Dividend & Yield
N/A (N/A)